Research Highlights: In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor medication had a lower risk of a subsequent stroke, heart attack or death compared to peers who were not prescribed the medications during a three-year follow up period
Our experienced medical professionals tailor treatment plans to each patient's unique needs, ensuring personalized care and optimal results
Obesity should be looked at the same way, he says
As an injectable medication, it has shown promising effects in controlling hunger and promoting weight loss by targeting areas of the brain that influence food intake
These lipids, called PAHSAs (palmitic acid esters of hydroxy-stearic acids), ease insulin resistance alone and curb inflammation, improving odds against heart attacks and strokes